Navigation Links
First study into GM Atlantic salmon mating reveals danger of escape to wild gene pool
Date:7/13/2011

If genetically modified Atlantic salmon were to escape from captivity they could succeed in breeding and passing their genes into the wild, Canadian researchers have found. Their research, published in Evolutionary Applications, explores the potential reproductive implications of GM salmon as they are considered for commercial farming.

"The use of growth-enhancing transgenic technologies has long been of interest to the aquaculture industry and now genetically modified Atlantic salmon is one of the first species to be considered for commercial farming. Yet, little is known about the potential impact on wild salmon populations if the GM species were to escape captivity," said lead author Darek Moreau from the Memorial University of Newfoundland, Canada.

One of the key concerns about a transgene escape is the "Trojan gene effect", caused when a GM fish outcompetes or reproduces equally against wild rivals, however if the resulting offspring are genetically inferior this could lead a species towards eventual extinction. Until now there is no empirical research to demonstrate the ability of transgenic Atlantic salmon to breed naturally and infiltrate the wild gene pool.

In the wild, reproducing males present two main forms of rivals which any escaping transgenic male would have to compete with; large males which have migrated and returned from the sea and smaller male parr which have matured in freshwater. The large males are aggressive and develop attributes to fight off their rivals, while the smaller male parr use cryptic colouring and 'sneak fertilisation' to compete.

To measure the ability of transgenic males to complete with wild males during the reproductive season the team monitored breeding behaviour in a naturalised laboratory setting and used genetic analysis to determine the success of competing individuals at producing offspring.

Large, migratory wild males outperformed their captivity-reared transgenic counterparts in terms of a variety of spawning behaviours. Moreover, despite being less aggressive, non-transgenic male parr were also able to outperform their GM rivals in terms of spawning behaviour, and as a result, achieved higher overall fertilisation success.

"While the transgenic males displayed reduced breeding performance relative to their non-transgenic rivals they still demonstrated the ability to successfully participate in natural spawning events and thus have the potential to contribute modified genes to wild populations," said Moreau. While the study provides an estimate of breeding performance under only a single set of physical and demographic environmental conditions, it does mimic a likely invasion scenario where the genetic background of the transgenic population differs from that of the wild population.

"Our study provides the first empirical observations on the natural reproductive capacities of growth hormone transgenic Atlantic salmon," concluded Moreau. "While the resulting ecological and genetic effects of a transgene escape remain uncertain, these data highlight the importance of preventing reproductively-viable GM salmon from entering natural systems."


'/>"/>

Contact: Ben Norman
Lifesciencenews@wiley.com
44-124-377-0375
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Scientists discover first gonorrhea strain resistant to all available antibiotics
2. From deadly E. coli to endangered polar bears: GigaScience provides first citable data
3. Broadlawns Installs First-in-Iowa Biometric Patient Identity Security System
4. For the first time, the European IVF Monitoring Group reports on cycles using frozen eggs
5. First whole-genome lung cancer study by TGen and Virginia G. Piper Cancer Center set for conference
6. The loudest animal is recorded for the first time
7. New study documents first cookiecutter shark attack on a live human
8. First joint ESC/EAS guidelines for the management of dyslipidaemias
9. Prodigal plankton species makes first known migration from Pacific to Atlantic via Pole
10. Elsevier and ADSA announce winners of first annual Journal of Dairy Science Most Cited Awards
11. First genetic mutation linked to heart failure in pregnant women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: